Chemed Co. (NYSE:CHE) Position Increased by TD Asset Management Inc

TD Asset Management Inc increased its position in shares of Chemed Co. (NYSE:CHE) by 23.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 254,953 shares of the company’s stock after acquiring an additional 49,176 shares during the period. TD Asset Management Inc owned about 1.68% of Chemed worth $163,662,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. William Allan Corp increased its stake in shares of Chemed by 1.0% in the first quarter. William Allan Corp now owns 7,494 shares of the company’s stock worth $4,811,000 after purchasing an additional 71 shares during the period. Entropy Technologies LP acquired a new stake in Chemed during the first quarter worth about $790,000. ProShare Advisors LLC grew its position in Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after buying an additional 49,808 shares in the last quarter. Headlands Technologies LLC acquired a new stake in Chemed during the first quarter worth about $510,000. Finally, Inspire Investing LLC grew its position in Chemed by 3.9% during the first quarter. Inspire Investing LLC now owns 5,073 shares of the company’s stock worth $3,256,000 after buying an additional 192 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Patrick P. Grace sold 284 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the transaction, the director now owns 3,270 shares in the company, valued at approximately $1,769,004.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Chemed news, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the sale, the director now owns 3,270 shares in the company, valued at approximately $1,769,004.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total transaction of $816,255.00. Following the sale, the chief executive officer now owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Insiders sold 5,784 shares of company stock worth $3,240,053 in the last quarter. Insiders own 3.32% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Royal Bank of Canada decreased their target price on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st.

Chemed Price Performance

Shares of CHE traded up $1.69 on Thursday, hitting $550.90. The company’s stock had a trading volume of 18,325 shares, compared to its average volume of 83,130. The company has a market capitalization of $8.34 billion, a PE ratio of 29.57, a PEG ratio of 2.25 and a beta of 0.43. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The company has a 50 day moving average price of $546.88 and a 200 day moving average price of $584.73.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a return on equity of 30.52% and a net margin of 12.36%. On average, equities analysts forecast that Chemed Co. will post 21.54 EPS for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend was Thursday, May 30th. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.